Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Current Leases (2019 - 2020)

Akebia Therapeutics (AKBA) has disclosed Current Leases for 2 consecutive years, with $5.1 million as the latest value for Q1 2020.

  • Quarterly Current Leases fell 83.72% to $5.1 million in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $5.1 million through Mar 2020, down 83.72% year-over-year, with the annual reading at $5.0 million for FY2019, N/A changed from the prior year.
  • Current Leases for Q1 2020 was $5.1 million at Akebia Therapeutics, up from $5.0 million in the prior quarter.
  • The five-year high for Current Leases was $31.3 million in Q1 2019, with the low at $4.8 million in Q2 2019.